Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis With Translocation (11;14)
Conditions:   Light Chain (AL) Amyloidosis;   CCND1 Translocation;   Venetoclax Interventions:   Drug: Venetoclax;   Drug: Dexamethasone Oral Sponsor:   Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials

FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Condition:   Light Chain Amyloidosis Intervention:   Drug: FKC288 Sponsor:   Nanjing University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials